Advertisements



Arcturus Therapeutics announces redomiciliation to U.S. as Delaware corporation

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJun 13th, 2019

Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update

Arcturus Therapeutics Announces Second Quarter Financial Results and Provides a Corporate Update.....»»

Category: earningsSource: benzingaAug 15th, 2019

Arcturus Therapeutics Announces First Quarter Financial Results and Provides a Corporate Update

SAN DIEGO, May 13, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (NASDAQ:ARCT), a leading messenger RNA medicines company focused on the discovery, development and commercializatio.....»»

Category: earningsSource: benzingaMay 13th, 2019

MabVax Therapeutics announces filing of Delaware petition

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJul 27th, 2018

BioXcel Therapeutics announces BXCL501 initiative for wearable digital devices

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewall18 hr. 49 min. ago

Leap Therapeutics announces update on Phase 2 clinical trial of DKN-01

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 17th, 2019

Nucor Announces Guidance for Third Quarter of 2019 Earnings

CHARLOTTE, N.C., Sept. 16, 2019 /PRNewswire/ --┬áNucor Corporation (NYSE:NUE) today announced guidance for its third quarter ending September 28, 2019. Nucor expects third quarter earnings to be in the range of $0.75 to $0.80 per diluted share. This ran.....»»

Category: earningsSource: benzingaSep 16th, 2019

Ovid Therapeutics announces first patient randomized in Phase 3 NEPTUNE trial

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 12th, 2019

Novelion Therapeutics announces U.S. court confirmation of Aegerion case

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

United Therapeutics announces FDA acceptance of Trevyent NDA for review

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 11th, 2019

Arcturus Therapeutics Holdings (ARCT) Investor Presentation - Slideshow

Arcturus Therapeutics Holdings (ARCT) Investor Presentation - Slideshow.....»»

Category: topSource: seekingalphaSep 10th, 2019

Oncternal Therapeutics announces management appointments

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytSep 9th, 2019

Aileron Therapeutics announces CFO Don Dougherty to depart

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: worldSource: nytSep 9th, 2019

Phio Pharmaceuticals announces research collaboration with Carisma Therapeutics

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 9th, 2019

Spero Therapeutics announces resignation of CFO Joel Sendek

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 9th, 2019

Brady Corporation Reports Fiscal 2019 Fourth Quarter Results and Announces its Fiscal 2020 EPS Guidance

Income before income taxes was $47.1 million in the fourth quarter of fiscal 2019 compared to $45.2 million in the fourth quarter of fiscal 2018......»»

Category: earningsSource: benzingaSep 6th, 2019

Windtree Therapeutics announces publication of ADS lung deposition study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 6th, 2019

Royal Financial, Inc. Announces Audited Fiscal Year 2019 Fourth Quarter and Year End Earnings Results

CHICAGO, Sept. 05, 2019 (GLOBE NEWSWIRE) -- Royal Financial, Inc. (the "Company") (OTCQX:RYFL), incorporated under the laws of Delaware on December 15, 2004, for the purpose of serving as the h.....»»

Category: earningsSource: benzingaSep 5th, 2019

Neon Therapeutics announces publication of study on cancer neoantigens

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

LRAD Corporation announces $1.1M homeland security order from Southeast Asia

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019

Global Blood Therapeutics announces FDA acceptance of NDA for voxelotor

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallSep 5th, 2019